Wow that is great news, so happy to hear. Does it actually work?
Please see the below link
First HBV Patient Dosed in Phase IIa Clinical Trial of ASC22, a Subcutaneously Administered PD-L1 Antibody
myrcludex is useful in combination for hbv infection.peg+myrcludex had hbsag loss increased to 27% but hbv cure is very close by replicor and many other drug combinations that it is not worth to use peginterferon due to the severe side effects
Hi Hepbcurepls - I sent you a message a few weeks ago. Did you get it? Thx.